Form ARS REGENERON PHARMACEUTICAL For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
- Topaz Labs releases Mac-focused update, 2X faster results for upscaling & enhancing images
- Best Crypto to Buy Now Sits in Presale While Dogecoin and XRP Face Tough Recovery Math
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
